[Featured Stock] Yuhan Yanghaeng Rises Over 20% on News of Supplying Raw Materials to US Big Pharma

Yuhan Corporation's stock price surged more than 20% on the 20th following news that it will supply pharmaceutical raw materials to a major U.S. big pharma company.

Yuhan Corporation Central Research Institute Exterior [Photo by Yuhan Corporation]

As of 10:20 a.m. that day, Yuhan Corporation was trading at 151,600 KRW, up 20.80% from the previous day's closing price. The stock started the session with a slight increase and continued to expand its gains throughout the morning trading session.

Yuhan Corporation announced that it had signed a supply contract with Gilead Sciences for the active pharmaceutical ingredient (API) of an HIV (Human Immunodeficiency Virus) treatment drug.

The contract amount is approximately 107 billion KRW, accounting for about 7.59% of the recent annual sales. The contract period is from today, September 20, until September 30, 2025.

This content was produced with the assistance of AI translation services.